ArticleNucleic acids research2026
CSsingle: a unified tool for robust decomposition of bulk and spatial transcriptomic data across diverse single-cell references.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- NicheDeSig: niche-aware deconvolution and adaptive signature analysis for spatial transcriptomics.Bioinformatics (Oxford, England) · 2026Article
- scGenoByte: a GenoByte embedding transformer with biological priors for cell type annotation.Briefings in bioinformatics · 2026Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Accurate deconvolution of bulk and spatial transcriptomes is essential for studying tissue architecture and disease, yet remains challenged by unmodeled differences in cellular RNA content and cross-source heterogeneity. We introduce CSsingle, a unified deconvolution framework that explicitly corrects for cell-type-specific RNA content differences using either External RNA Controls Consortium (ERCC) spike-ins or a computational estimator, while robustly harmonizing data across platforms. CSsingle employs an iteratively reweighted least-squares model initialized by marker-gene sectional linearity, enabling accurate inference of cell-type proportions from diverse single-cell references. In bulk data, CSsingle outperforms existing methods by correcting systematic errors, including neutrophil underestimation in blood and tumor purity underestimation in breast tumor. Applied to spatial transcriptomics, CSsingle enables fine-grained mapping of cellular organization in the developing human pancreas and reveals functionally distinct niches in colon cancer. By integrating cell size awareness with cross-platform robustness, CSsingle advances the integrative analysis of complex tissues.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.